KORU Medical Systems, Inc.: Topline Capital Management, LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Topline Capital Management, LLC amended its Schedule 13G stake filing for KORU Medical Systems, Inc., according to SEC accession 0001792549-26-000038. The filing updates the investment firm's reported ownership position in the medical device maker. Schedule 13G amendments are typically filed by passive investors whose holdings cross or change relative to the 5% threshold. The revision signals a shift in Topline's beneficial ownership interest in KORU. Investors will watch for further 13G or 13D filings to gauge whether the position continues to change.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
KORU Medical Systems, Inc., Topline Capital Management, LLC